Invention Application
- Patent Title: AMINOIMIDAZOPYRIDAZINES AS KINASE INHIBITORS
-
Application No.: US16758892Application Date: 2018-10-29
-
Publication No.: US20200277296A1Publication Date: 2020-09-03
- Inventor: Michael E. Mertzman , Carolyn Diane Dzierba , Jason M. Guernon , Amy C. Hart , Guanglin Luo , John E. Macor , William J. Pitts , Jianliang Shi , Steven H. Spergel
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- International Application: PCT/US2018/057968 WO 20181029
- Main IPC: C07D487/04
- IPC: C07D487/04
Abstract:
Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, (I) are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.
Public/Granted literature
- US11440913B2 Aminoimidazopyridazines as kinase inhibitors Public/Granted day:2022-09-13
Information query
